Literature DB >> 24667534

Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro.

Katalin Módis1, Ciro Coletta1, Antonia Asimakopoulou2, Bartosz Szczesny1, Celia Chao3, Andreas Papapetropoulos2, Mark R Hellmich3, Csaba Szabo4.   

Abstract

Recent data show that colon cancer cells selectively overexpress cystathionine-β-synthase (CBS), which produces hydrogen sulfide (H2S), to maintain cellular bioenergetics, support tumor growth and stimulate angiogenesis and vasorelaxation in the tumor microenvironment. The purpose of the current study was to investigate the effect of the allosteric CBS activator S-adenosyl-L-methionine (SAM) on the proliferation and bioenergetics of the CBS-expressing colon cancer cell line HCT116. The non-transformed, non-tumorigenic colon epithelial cell line NCM356 was used as control. For assessment of cell proliferation, the xCELLigence system was used. Bioenergetic function was measured by Extracellular Flux Analysis. Experiments using human recombinant CBS or HCT116 homogenates complemented the cell-based studies. SAM markedly enhanced CBS-mediated H2S production in vitro, especially when a combination of cysteine and homocysteine was used as substrates. Addition of SAM (0.1-3 mM) to HCT116 cells induced a concentration-dependent increase H2S production. SAM exerted time- and concentration-dependent modulatory effects on cell proliferation. At 0.1-1 mM SAM increased HCT116 proliferation between 0 and 12 h, while the highest SAM concentration (3 mM) inhibited proliferation. Over a longer time period (12-24 h), only the lowest concentration of SAM used (0.1 mM) stimulated cell proliferation; higher SAM concentrations produced a concentration-dependent inhibition. The short-term stimulatory effects of SAM were attenuated by the CBS inhibitor aminooxyacetic acid (AOAA) or by stable silencing of CBS. In contrast, the inhibitory effects of SAM on cell proliferation was unaffected by CBS inhibition or CBS silencing. In contrast to HCT116 cells, the lower rate of proliferation of the low-CBS expressor NCM356 cells was unaffected by SAM. Short-term (1 h) exposure of HCT116 cells to SAM induced a concentration-dependent increase in oxygen consumption and bioenergetic function at 0.1-1 mM, while 3 mM was inhibitory. Longer-term (72 h) exposure of HCT116 cells to all concentrations of SAM tested suppressed mitochondrial oxygen consumption rate, cellular ATP content and cell viability. The stimulatory effect of SAM on bioenergetics was attenuated in cells with stable CBS silencing, while the inhibitory effects were unaffected. In NCM356 cells SAM exerted smaller effects on cellular bioenergetics than in HCT116 cells. We have also observed a downregulation of CBS in response to prolonged exposure of SAM both in HCT116 and NCM356 cells. Taken together, the results demonstrate that H2S production in HCT116 cells is stimulated by the allosteric CBS activator, SAM. At low-to intermediate levels and early time periods the resulting H2S serves as an endogenous cancer cell growth and bioenergetic factor. In contrast, the inhibition of cell proliferation and bioenergetic function by SAM does not appear to relate to adverse autocrine effects of H2S resulting from CBS over-stimulation but, rather to CBS-independent pharmacological effects.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allosteric modulation; Bioenergetics; Colorectal cancer; Mitochondria; Proliferation

Mesh:

Substances:

Year:  2014        PMID: 24667534      PMCID: PMC4156891          DOI: 10.1016/j.niox.2014.03.001

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  55 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  Oxygen-sensitive mitochondrial accumulation of cystathionine β-synthase mediated by Lon protease.

Authors:  Huajian Teng; Bo Wu; Kexin Zhao; Guangdong Yang; Lingyun Wu; Rui Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

Review 3.  S-adenosylmethionine (SAMe) as treatment for depression: a systematic review.

Authors:  Anna-leila Williams; Christine Girard; Danny Jui; Alyse Sabina; David L Katz
Journal:  Clin Invest Med       Date:  2005-06       Impact factor: 0.825

4.  Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro.

Authors:  Ye Zhao; Jian-Sheng Li; Ming-Zhou Guo; Bai-Sui Feng; Jin-Ping Zhang
Journal:  Chin J Cancer       Date:  2010-08

5.  Oxidative stress suppresses the cellular bioenergetic effect of the 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway.

Authors:  Katalin Módis; Antonia Asimakopoulou; Ciro Coletta; Andreas Papapetropoulos; Csaba Szabo
Journal:  Biochem Biophys Res Commun       Date:  2013-03-26       Impact factor: 3.575

Review 6.  Enzymology of H2S biogenesis, decay and signaling.

Authors:  Omer Kabil; Ruma Banerjee
Journal:  Antioxid Redox Signal       Date:  2013-06-07       Impact factor: 8.401

7.  Cystathionine beta-synthase is coordinately regulated with proliferation through a redox-sensitive mechanism in cultured human cells and Saccharomyces cerevisiae.

Authors:  Kenneth N Maclean; Miroslav Janosík; Eva Kraus; Viktor Kozich; Robert H Allen; Beverly K Raab; Jan P Kraus
Journal:  J Cell Physiol       Date:  2002-07       Impact factor: 6.384

8.  Identification of cystathionine β-synthase inhibitors using a hydrogen sulfide selective probe.

Authors:  Megan K Thorson; Tomas Majtan; Jan P Kraus; Amy M Barrios
Journal:  Angew Chem Int Ed Engl       Date:  2013-03-19       Impact factor: 15.336

9.  Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE).

Authors:  Antonia Asimakopoulou; Panagiotis Panopoulos; Christos T Chasapis; Ciro Coletta; Zongmin Zhou; Giuseppe Cirino; Athanassios Giannis; Csaba Szabo; Georgios A Spyroulias; Andreas Papapetropoulos
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

10.  Endogenously produced hydrogen sulfide supports tumor cell growth and proliferation.

Authors:  Csaba Szabo; Mark R Hellmich
Journal:  Cell Cycle       Date:  2013-08-21       Impact factor: 4.534

View more
  37 in total

1.  H2S-induced S-sulfhydration of lactate dehydrogenase a (LDHA) stimulates cellular bioenergetics in HCT116 colon cancer cells.

Authors:  Ashley A Untereiner; Gabor Oláh; Katalin Módis; Mark R Hellmich; Csaba Szabo
Journal:  Biochem Pharmacol       Date:  2017-04-09       Impact factor: 5.858

2.  A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?

Authors:  Xu Cao; Lei Ding; Zhi-Zhong Xie; Yong Yang; Matthew Whiteman; Philip K Moore; Jin-Song Bian
Journal:  Antioxid Redox Signal       Date:  2018-06-29       Impact factor: 8.401

Review 3.  A practical guide to working with H2S at the interface of chemistry and biology.

Authors:  Matthew D Hartle; Michael D Pluth
Journal:  Chem Soc Rev       Date:  2016-11-07       Impact factor: 54.564

4.  AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.

Authors:  Bartosz Szczesny; Katalin Módis; Kazunori Yanagi; Ciro Coletta; Sophie Le Trionnaire; Alexis Perry; Mark E Wood; Matthew Whiteman; Csaba Szabo
Journal:  Nitric Oxide       Date:  2014-04-19       Impact factor: 4.427

5.  Upregulation of Cystathionine-β-Synthase in Colonic Epithelia Reprograms Metabolism and Promotes Carcinogenesis.

Authors:  Ches'Nique M Phillips; John R Zatarain; Michael E Nicholls; Craig Porter; Steve G Widen; Ketan Thanki; Paul Johnson; Muhammad U Jawad; Mary P Moyer; James W Randall; Judith L Hellmich; Manjit Maskey; Suimin Qiu; Thomas G Wood; Nadiya Druzhyna; Bartosz Szczesny; Katalin Módis; Csaba Szabo; Celia Chao; Mark R Hellmich
Journal:  Cancer Res       Date:  2017-09-18       Impact factor: 12.701

6.  AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts: Relevance for Preeclampsia Pathogenesis.

Authors:  Ambart E Covarrubias; Edouard Lecarpentier; Agnes Lo; Saira Salahuddin; Kathryn J Gray; S Ananth Karumanchi; Zsuzsanna K Zsengellér
Journal:  Am J Pathol       Date:  2018-10-11       Impact factor: 4.307

Review 7.  Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.

Authors:  Karim Zuhra; Fiona Augsburger; Tomas Majtan; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-30

8.  Drug resistance induces the upregulation of H2S-producing enzymes in HCT116 colon cancer cells.

Authors:  Ashley A Untereiner; Athanasia Pavlidou; Nadiya Druzhyna; Andreas Papapetropoulos; Mark R Hellmich; Csaba Szabo
Journal:  Biochem Pharmacol       Date:  2017-10-20       Impact factor: 5.858

Review 9.  The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer.

Authors:  Mark R Hellmich; Ciro Coletta; Celia Chao; Csaba Szabo
Journal:  Antioxid Redox Signal       Date:  2014-06-20       Impact factor: 8.401

10.  Cystathionine-beta-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approach.

Authors:  Celia Chao; John R Zatarain; Ye Ding; Ciro Coletta; Amy A Mrazek; Nadiya Druzhyna; Paul Johnson; Haiying Chen; Judy L Hellmich; Antonia Asimakopoulou; Kazunori Yanagi; Gabor Olah; Petra Szoleczky; Gabor Törö; Fredrick J Bohanon; Minal Cheema; Rachel Lewis; David Eckelbarger; Akbar Ahmad; Katalin Módis; Ashley Untereiner; Bartosz Szczesny; Andreas Papapetropoulos; Jia Zhou; Mark R Hellmich; Csaba Szabo
Journal:  Mol Med       Date:  2016-05-16       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.